bpc 157 fda warning 2025 september scientists flag concerns with peptides as RFK Jr. tries to ease access : NPR FDA Signals Potentially Evolving Stance

FDA Signals Potentially Evolving Stance Toward Compounding of Certain Peptides Life Sciences Perspectives FDA's Review Of Peptides Signals A Growing Public Health Challenge The FDA panel will review seven peptides and decide if they should be added to a list of substances that can be safely produced by compounding pharmacies. FDA is reviewing seven peptides this week, BPC 157, MOTS c, and Epitalon among them. Committee meets Thursday and Friday, and the likely outcome is tighter restrictions on compounding pharmacies. Read past the headline

SKU: 8150150288 · From composequickly.com